Badan POM, The Indonesian Food and Drug Administration, has issued an Emergency Use Authorization (EUA) to permit the emergency use of Favipiravir for the management of adult patients (aged 18 years and older) with mild to moderate COVID-19, combined with standard supportive care.
The Emergency Use Authorization of Favipiravir is for the management of adult patients (aged 18 years and older) with mild to moderate COVID-19, combined with standard supportive care.